Literature DB >> 10180741

How well do in vitro particle size measurements predict drug delivery in vivo?

S P Newman1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 10180741

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN： 0894-2684


× No keyword cloud information.
  11 in total

Review 1.  Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?

Authors:  S P Newman
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

2.  In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler.

Authors:  Peter H Hirst; Gary R Pitcairn; Jeff G Weers; Thomas E Tarara; Andrew R Clark; Luis A Dellamary; Gail Hall; Jolene Shorr; Stephen P Newman
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

Review 3.  In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Authors:  Jolyon Mitchell; Steve Newman; Hak-Kim Chan
Journal:  AAPS PharmSciTech       Date:  2007-12-21       Impact factor: 3.246

Review 4.  Deposition and effects of inhaled corticosteroids.

Authors:  Stephen P Newman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.

Authors:  Yung Sung Cheng
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

6.  Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers.

Authors:  L M Cass; J Brown; M Pickford; S Fayinka; S P Newman; C J Johansson; A Bye
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

7.  Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.

Authors:  Thomas E Tarara; Michael S Hartman; Howard Gill; Alan A Kennedy; Jeffry G Weers
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

8.  Influence of fluoxetine on olanzapine pharmacokinetics.

Authors:  Denis Gossen; Jean-Marie de Suray; Francois Vandenhende; Claude Onkelinx; Diamon Gangji
Journal:  AAPS PharmSci       Date:  2002

9.  Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.

Authors:  Jolyon P Mitchell; Jason A Suggett
Journal:  AAPS PharmSciTech       Date:  2014-06-04       Impact factor: 3.246

Review 10.  The Diskus: a review of its position among dry powder inhaler devices.

Authors:  H Chrystyn
Journal:  Int J Clin Pract       Date:  2007-06       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.